Bharat Biotech's 1st nasal COVID vaccine gets approval for phase 2 trial
Aug 14, 2021, at 02:49 am
New Delhi/IBNS: Bharat Biotech has received phase 2 human clinical trial nod for its nasal COVID vaccine, called BBV154, the Union Government informed on Friday.